Analytical Data
-
基因名
SENP7
-
简介
SENP7, a versatile protease, positively regulates the cGAS-STING pathway by desumoylating CGAS, enhancing its DNA-binding and activation. Specific to SUMO2 and SUMO3, SENP7 proficiently deconjugates poly-SUMO2 and poly-SUMO3 chains, dynamically regulating protein sumoylation. While less efficient in processing full-length SUMO proteins, SENP7's role in modulating the cGAS-STING pathway highlights its importance in innate immune responses. SENP7 Protein, Human is the recombinant human-derived SENP7 protein, expressed by E. coli , with tag free.
- Application
-
别名
Sentrin-Specific Protease 7; SUMO-1-Specific Protease 2; Sentrin/SUMO-Specific Protease SENP7; SENP7; KIAA1707; SSP2; SUSP2
-
种属
Human
-
表达系统
E. coli
-
标签
Tag Free
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BQF6-1
-
表达区间
M695-A864
-
蛋白长度
Partial
-
分子量
22 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SENP7, a member of the Sentrin/SUMO-specific protease (SENP) family, plays a crucial role in the regulation of the SUMO (Small Ubiquitin-like Modifier) modification pathway, which is vital for various cellular processes including transcription, DNA repair, and stress responses. Unlike other SENPs, SENP7 exhibits unique substrate specificity and is known to remove SUMO chains from specific target proteins, thereby influencing their stability and activity. The dysregulation of SENP7 has been linked to several pathological conditions, including cancer and neurodegenerative diseases, making it a potential therapeutic target. Research on recombinant SENP7 protein is essential for understanding its biochemical properties, enzymatic functions, and interaction with SUMO-conjugated substrates. By producing and purifying recombinant SENP7 in a controlled laboratory setting, scientists aim to elucidate its structural characteristics and catalytic mechanisms. Furthermore, the study of recombinant SENP7 is critical in developing high-throughput screening assays to identify small molecule inhibitors or activators, which could lead to novel treatments for diseases associated with SUMOylation dysregulation. Overall, the investigation of SENP7 recombinant protein serves as a foundational step in unraveling the complexities of SUMO signaling and its implications in human health.
